RightHealth

Posts Tagged ‘PML’

April 9, 2009

Psoriasis Drug Raptiva Off The Market »

psoriasis-drug-raptiva1California based drug maker Genentech announced this week the withdrawal of the drug Raptiva from the US market. Raptiva, also known as efalizumab, is used in the treatment of the skin condition psoriasis. The move comes after the FDA noted the deathes of three people from a rare brain disease called progressive multifocal leukoencephalopathy while taking Raptiva. Genentech estimates about 2,000 patients in the US may currently be using Raptiva. Those who are actively using the medication should stop using it and speak to their physicians about alternative treatment.  Raptiva will no longer be available after June 8, 2009.

Read more and share your opinion.

Post to Twitter Tweet This Post to Facebook Share on Facebook